Industry news that matters to you.  Learn more

Archives for August 2012

Quintiles Acquires Expression Analysis, Premier Provider of Genomics Services, to Advance Personalized Medicine

To help biopharmaceutical companies dramatically improve drug development productivity and deliver greater value, Quintiles recently announced the acquisition of Expression Analysis, Inc. (EA), a premier provider of genomics testing and analysis to biopharma, academic, government and non-profit customers.

Nodality Enters into a Multi-year Strategic Collaboration with Pfizer in Autoimmune Disease

Nodality, Inc. recently announced a strategic collaboration with Pfizer Inc. for the use of Nodality’s proprietary Single Cell Network Profiling (SCNP) technology as a tool for the development of Pfizer compounds. The agreement establishes a multi-year, collaborative effort that will initially focus on providing biological bases for streamlining the development of potential Pfizer compounds for autoimmune disease with an initial focus on Lupus, including characterizing mechanisms of action, disease analysis, and drug profiling. The agreement also provides Pfizer the option to engage Nodality in companion diagnostics development. The terms of the agreement include an upfront payment, R&D funding, and success-based milestone payments.

SomaLogic Webinar: Unlocking Protein Biomarker Discovery for Pharma, Biotech and Academia

Xtalks presents a live webinar on August 23, 2012 at 11:00am EDT on protein biomarker discovery. Dr. Steve Williams, Chief Medical Officer, SomaLogic, and Dr. Nick Saccomano, Chief Technology Officer, SomaLogic, will discuss a transformative proteomic biomarker discovery technology developed by SomaLogic that measures over 1129 human proteins in small sample volumes (50 µL) with a sensitive, specific and semi-automated assay.

Selventa CEO David de Graaf Named as one of PharmaVOICE Magazine’s “100 Most Inspiring People in the Life Sciences”

Selventa, a biomarker discovery company that enables personalized healthcare, today announced that David de Graaf, Selventa’s President and Chief Executive Officer, has been selected as one of PharmaVOICE Magazine’s “100 Most Inspiring People in the Life Sciences.”

University of Leicester Announces Record £7 Million Donation with Creation of Biomarker Facility

The University of Leicester recently announced a record £7 million ($11 million USD) donation – the biggest in the University’s history since its inception in 1921. The donation from the John and Lucille van Geest Foundation will enable the University to build a new Biomarker Facility adjacent to the University’s Cardiovascular Research Centre at Glenfield Hospital. This will help pave the way for a new era of ‘personalised medicine’ enabling the University to create a facility that is unique in the UK and that can compete globally.